Omega-3 fatty acids for ADHD in children and teens with low omega-3

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 12-week randomized, placebo-controlled trial enrolling children and adolescents diagnosed with ADHD who also have omega-3 deficiency. Participants who have had no changes in ADHD treatment for at least 4 weeks are randomized to receive EPA, DHA, or a placebo. Symptom thresholds for enrollment use the SNAP-IV inattentive and hyperactive subscales, and outcomes will compare ADHD symptoms between active and placebo groups over 12 weeks. The trial is conducted at China Medical University Hospital with standard safety exclusions for medical and major psychiatric comorbidities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. DSM-5 diagnosis of ADHD
2. Did not have any changes of ADHD treatment (pharmacological/psychological) within 4 weeks of entering the trial.
3. SNAP-IV inattention subscale \>=12, or hyperactivity subscale \>=12, or inattention+ hyperactivity subscales \>=24

Exclusion Criteria:

1. IQ\<80
2. Allergic to omega-3
3. Physical disorders: thyroid function, cancer
4. Psychiatric comorbidity: SUD, psychotic disorders, bipolar disorder, major depressive disorder

Where it's running

• China Medical University Hospital
  Taichung, Taiwan Recruiting

Study contacts

• Principal investigator: Pei-Chen Chang, PhD — China Medical University Hospital
• Study coordinator: Pei-Chen Chang, PhD
• Email: 013121@tool.caaumed.org.tw
• Phone: +88622052121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers that predict medication-related side effects in children with ADHD

  This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07900451

• Group CBT vs. Activity Group for Adults with ADHD

  This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.

  Recruiting at 2 sites Region Stockholm · Stockholm and 1 other locations · NCT07834437

• Central Executive Training and Behavioral Parent Training for Young Children with ADHD

  This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.

  Recruiting Florida State University · Tallahassee, Florida · NCT07784348

• Solriamfetol for ADHD in teens: see if it helps with focus

  This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.

  Recruiting at 31 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 30 other locations · NCT07717892

• Solriamfetol for children with ADHD: a 6-week comparison to placebo

  This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.

  Recruiting at 32 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 31 other locations · NCT07717879

• Impact of Sleep Timing and Duration on Teens with ADHD

  This study tests how changing how long and when teens with ADHD sleep affects their attention and daily functioning.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07684417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.